Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 9 papers. Top paper: “A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non–Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1”.
Dijana Djureinovic, Shlomit Jessel, Irina Krykbaeva, Lin Zhang, Lucia Jilaveanu +17 more
Ondřej Bláha, Denise Esserman, Daniel Zelterman, Michael J. Kane, Rachael Liu +2 more
Joan K. Monin, Naomi Isenberg, Daniel Zelterman, Becca R. Levy, E‐Shien Chang
Michael J. Kane, Denise Esserman, Ondřej Bláha, Daniel Zelterman, Wei Wei +1 more
Daniel Zelterman, Chang Yu
Qun Lin, Daniel Zelterman, Zhong Yun, Yuri Kim
Dijana Djureinovic, Shlomit Jessel, Irina Krykbaeva, Lin Zhang, Lucia B. Jilaveanu +17 more
Ondřej Bláha, Michael J. Kane, Wei Wei, Denise Esserman, Daniel Zelterman +1 more
Joan K. Monin, Daniel Zelterman, Becca R. Levy, E‐Shien Chang